|
|
| Line 1: |
Line 1: |
| [[Image:1ld5.jpg|left|200px]] | | {{Seed}} |
| | [[Image:1ld5.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1ld5| PDB=1ld5 | SCENE= }} | | {{STRUCTURE_1ld5| PDB=1ld5 | SCENE= }} |
|
| |
|
| '''STRUCTURE OF BPTI MUTANT A16V'''
| | ===STRUCTURE OF BPTI MUTANT A16V=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Here we determined NMR solution structures of two mutants of bovine pancreatic trypsin inhibitor (BPTI) to reveal structural reasons of their decreased thermodynamic stability. A point mutation, A16V, in the solvent-exposed loop destabilizes the protein by 20 degrees C, in contrast to marginal destabilization observed for G, S, R, L or W mutants. In the second mutant introduction of eight alanine residues at proteinase-contacting sites (residues 11, 13, 17, 18, 19, 34, 37 and 39) provides a protein that denatures at a temperature about 30 degrees C higher than expected from additive behavior of individual mutations. In order to efficiently determine structures of these variants, we applied a procedure that allows us to share data between regions unaffected by mutation(s). NOAH/DYANA and CNS programs were used for a rapid assignment of NOESY cross-peaks, structure calculations and refinement. The solution structure of the A16V mutant reveals no conformational change within the molecule, but shows close contacts between V16, I18 and G36/G37. Thus, the observed 4.3kcal/mol decrease of stability results from a strained local conformation of these residues caused by introduction of a beta-branched Val side-chain. Contrary to the A16V mutation, introduction of eight alanine residues produces significant conformational changes, manifested in over a 9A shift of the Y35 side-chain. This structural rearrangement provides about 6kcal/mol non-additive stabilization energy, compared to the mutant in which G37 and R39 are not mutated to alanine residues.
| | The line below this paragraph, {{ABSTRACT_PUBMED_12206780}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 12206780 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_12206780}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| 1LD5 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LD5 OCA]. | | 1LD5 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LD5 OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Line 26: |
Line 30: |
| [[Category: Bpti]] | | [[Category: Bpti]] |
| [[Category: Kunitz fold]] | | [[Category: Kunitz fold]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 23:48:11 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 12:27:20 2008'' |